Ways to Save
First Order Bonus · +10%ATMI Labs is completing final preparations for launch. Browse the research catalog and join the notification list for ordering access.
Premium Research Compounds
Batch-tested research compounds backed by batch-specific analytical testing and Certificates of Analysis, for laboratory research.
- Batch-Specific Testing & COAs
- Analytical Testing Documentation
- Transparent Batch Verification
Research Portal
Featured Research Compound
Explore the science behind each ATMI Labs category. Swipe to browse every compound in the selected category.
5-Amino-1MQ
5-Amino-1-methylquinolinium iodide
Research Overview
A small-molecule methylquinolinium compound investigated as a selective inhibitor of nicotinamide N-methyltransferase (NNMT) in adipocyte and muscle research.
Mechanism of Action
Competitively inhibits NNMT, sparing intracellular nicotinamide and S-adenosylmethionine pools and elevating NAD⁺ and polyamine availability in adipose and skeletal-muscle tissue.
Current Research Focus
Investigated in adipocyte hypertrophy, diet-induced obesity models, aged skeletal-muscle regeneration, and NAD⁺-methylation crosstalk studies.
- Testing
- Batch-specific
- Mol. Weight
- 286.11 g/mol
- CAS
- 62226-49-9
- Format
- Lyophilized
Retatrutide
GIP / GLP-1 / Glucagon triple agonist
Research Overview
A synthetic triple incretin peptide investigated for its role in glucose homeostasis, adipose signaling, and energy partitioning research.
Mechanism of Action
Concurrent agonism of the GLP-1, GIP, and glucagon receptors, engaging complementary incretin and hepatic pathways that modulate insulin secretion, energy expenditure, and lipolysis.
Current Research Focus
Studied in preclinical work on insulin sensitivity, lipid oxidation, hepatic steatosis, and body-composition dynamics with a distinct glucagon-driven energy-expenditure signature.
- Testing
- Batch-specific
- Mol. Weight
- 4731.4 g/mol
- CAS
- 2381089-83-2
- Format
- Lyophilized
Semaglutide
GLP-1 analogue
Research Overview
A long-acting GLP-1 receptor analogue with amino-acid substitutions and a C-18 fatty-acid chain enabling albumin binding and once-weekly kinetics.
Mechanism of Action
Selectively activates GLP-1 receptors to potentiate glucose-dependent insulin release, suppress glucagon, slow gastric emptying, and engage central hypothalamic satiety circuits.
Current Research Focus
Studied in type-2 diabetes glycemic-control models, food-intake signaling pathways, cardiovascular biomarker, and comparative research against dual and triple incretin agonists.
- Testing
- Batch-specific
- Mol. Weight
- 4113.6 g/mol
- CAS
- 910463-68-2
- Format
- Lyophilized
Tirzepatide
GIP / GLP-1 dual agonist
Research Overview
A dual GIP and GLP-1 receptor agonist engineered as a single peptide combining two incretin activities in one molecule.
Mechanism of Action
Simultaneously activates GIP and GLP-1 receptors on pancreatic β-cells and hypothalamic neurons, enhancing glucose-dependent insulin secretion, delaying gastric emptying, and reducing food-intake signaling.
Current Research Focus
Investigated in glycemic control, body-composition models, lipid-profile, and comparative incretin-pathway research versus mono-agonists.
- Testing
- Batch-specific
- Mol. Weight
- 4813.5 g/mol
- CAS
- 2023788-19-2
- Format
- Lyophilized
Browse the catalog
Find your research focus
- Growth Hormone5 compounds
- Metabolic4 compounds
- Tissue & Cellular4 compounds
- Bioenergetics2 compounds
- Longevity & Regeneration6 compounds
- Neuroendocrine4 compounds
- Cognitive & Neuro4 compounds
- Research Essentials1 compound
Batch-tested research compounds
ATMI Labs maintains batch-specific analytical testing and Certificates of Analysis for the research compounds we distribute. Available documentation may include purity, content/identity, endotoxin testing, and independent laboratory analysis associated with the applicable production batch.
FDA Disclaimer
Statements made regarding products offered by ATMI Labs have not been evaluated by the U.S. Food and Drug Administration. Products offered by ATMI Labs are intended exclusively for laboratory research and analytical purposes. They are not intended for human or veterinary use, consumption, or administration and are not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. Information presented on this website is provided solely for research and educational reference and does not constitute medical advice.